Based on these findings, it is postulated that the RhoA G17V mutation is a driver event for the development of nMTCL-TFH-phenotype, although it can still be found in neoplasms of different histogenesis, such as Burkitt’s lymphoma (BL), adult T-cell leukemia/lymphoma (ATLL) and gastric adenocarcinomas (24, 50, 55–57). The gene discussed is RHOA; the disease is neoplasm.